Related Experiment Video
Updated: Nov 24, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Morbidity and Mortality in Patients Undergoing Mitral Valve Replacement at a Cardiovascular Surgery Referral Service:
Júlia Lasserre Moreira1, Pedro Henrique Andrade Araújo Salvatore Barletta1, José Augusto Baucia2
1Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Insights
Predictors of death after mitral valve replacement include older age, reduced ejection fraction (EF), and mitral regurgitation (MR). These factors are crucial for improving patient outcomes in cardiovascular surgery.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Surgery
- Medical Research
Background:
- Mitral valve replacement is a critical procedure for patients with severe mitral valve disease.
- Identifying factors influencing outcomes is essential for surgical planning and patient management.
Purpose of the Study:
- To identify predictors of morbidity and mortality in patients undergoing isolated mitral valve replacement.
- To analyze the impact of preoperative, intraoperative, and postoperative factors on patient outcomes.
Main Methods:
- Retrospective cohort study of 164 patients undergoing isolated mitral valve replacement (2011-2016).
- Data collected from medical records, including demographics, diagnoses, and surgical details.
- Statistical analysis using odds ratio (OR) and binary logistic regression.
Main Results:
- Mortality rate was 6.7%; common complication was postoperative arrhythmias (19.5%).
- Significant risk factors for death included endocarditis, reduced ejection fraction (EF) (<50%), and mitral regurgitation (MR).
- Older age and lower preoperative hemoglobin levels were associated with increased mortality.
Conclusions:
- Older age and reduced preoperative ejection fraction (EF) are significant predictors of death after mitral valve replacement.
- Preoperative endocarditis and mitral regurgitation (MR) are also associated with increased postoperative mortality.
Introduction:
We aimed to identify predictors of morbidity and mortality in patients undergoing isolated mitral valve replacement.
Methods:
This is a retrospective cohort study with 164 patients who underwent isolated mitral valve replacement at a referral hospital for cardiovascular diseases, which were performed from January 2011 to December 2016. Data were obtained from medical records, including preoperative, intraoperative, and postoperative information. Statistical analysis was performed to calculate odds ratio (OR), unpaired Student's t-test, and binary logistic regression. P-values < 0.05 were considered significant.
Results:
A total of 69.5% (n=114) of the patients had a diagnosis of rheumatic disease prior to surgery. Mortality rate was 6.7% (n=11). The most observed complication was the occurrence of postoperative arrhythmias (19.5%). On average, patients remained 5.34 days in the intensive care unit. There was a statistically significant enhanced risk of death among patients with previous diagnosis of endocarditis (OR 5.22, 95% confidence interval [CI] 1,368-19,915; P=0.008), reduced ejection fraction (EF) (< 50%) (OR 9.46, 95% CI 2,61-34,35; P<0.001), and mitral regurgitation (MR) (OR 7.7, 95% CI 1.576-37.545; P=0.004). Patients who died were older than those who survived surgery (P<0.001) and had lower preoperative serum hemoglobin levels (P=0.018). Logistic regression showed age and reduced EF at preoperative evaluation as predictors of death.
Conclusion:
Older age, reduced serum hemoglobin levels, preoperative diagnosis of endocarditis, reduced EF, and MR were associated with postoperative mortality. Age and reduced EF were predictors of death.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction

